Rises in fetal adenosine during hypoxia may have a metabolic inhibitory role that helps the fetus adapt to periods of low arterial partial pressure of oxygen (P a O 2 ). We examined the fetal cerebral hemodynamic and metabolic responses to exogenous adenosine infusion and compared this with previous studies. Six fetal sheep at ca. 125 d gestation were instrumented under general anesthesia with catheters, flow probes, and near-infrared optodes and allowed to recover. After 3 d, adenosine was infused at a level known to reproduce fetal levels during hypoxia. Fetal hemodynamics and cerebral near-infrared spectroscopic (NIRS) variables were monitored and paired blood samples taken for oxygen delivery and consumption calculation. Fetal heart rate, mean arterial pressure, and carotid flow showed no change during adenosine infusion. Cerebral oxyhemoglobin (HbO 2 ), deoxyhemoglobin (Hb), and blood volume rose, suggesting venous pooling in the brain. Cerebral cytochrome oxidase (CcO) became more oxidized, indicating reduction in electron flow down the mitochondrial electron transfer chain and, thus, a fall in metabolic rate. Blood sample analysis revealed that there was no change in oxygen delivery to the head but that cerebral oxygen consumption fell during adenosine infusion. These data indicate that fetal cerebral metabolism fell during infusion of adenosine at a level known to reproduce fetal plasma concentrations during hypoxia. Adenosine is a vasoactive purine metabolite produced during breakdown of high-energy phosphates in hypoxia. Tissue levels of adenosine are 2-3 times higher in the fetus than the adult (1) and have been shown to rise further within minutes of the onset of hypoxia in the ovine fetus (2). Plasma adenosine levels are also higher in hypoxemic, acidotic growth-retarded human fetuses than in appropriately grown fetuses (3). This may be seen as a direct consequence of the hypoxemia, but there is also the possibility that elevated tissue and plasma adenosine may form part of a protective fetal adaptation aimed at matching oxygen demand to availability (4, 5). Adenosine acting via A2 receptors is known to cause vasodilatation both in the peripheral and cerebral vascular beds, which improves cerebral blood flow and, thus, cerebral DO 2 (6, 7). Adenosine also inhibits fetal breathing and eye and body movements, depresses excitatory neurotransmission, and causes neuronal hyperpolarization, all of which will reduce fetal V O 2 (8, 9).
Adenosine is a vasoactive purine metabolite produced during breakdown of high-energy phosphates in hypoxia. Tissue levels of adenosine are 2-3 times higher in the fetus than the adult (1) and have been shown to rise further within minutes of the onset of hypoxia in the ovine fetus (2) . Plasma adenosine levels are also higher in hypoxemic, acidotic growth-retarded human fetuses than in appropriately grown fetuses (3) . This may be seen as a direct consequence of the hypoxemia, but there is also the possibility that elevated tissue and plasma adenosine may form part of a protective fetal adaptation aimed at matching oxygen demand to availability (4, 5) . Adenosine acting via A2 receptors is known to cause vasodilatation both in the peripheral and cerebral vascular beds, which improves cerebral blood flow and, thus, cerebral DO 2 (6, 7) . Adenosine also inhibits fetal breathing and eye and body movements, depresses excitatory neurotransmission, and causes neuronal hyperpolarization, all of which will reduce fetal V O 2 (8, 9) .
We have previously reported that mild hypoxemia in the ovine fetus is associated with an increase in CBV and in the cerebral concentration of CcO as measured by near-infrared spectroscopy (10) . We hypothesize that these changes are the result of the dual actions of endogenous adenosine on cerebral blood vessels and on cerebral metabolism. The aim of this study was, therefore, to determine whether adenosine administered exogenously to the chronically instrumented ovine fetus in utero would lead to similar changes in CBV and CcO redox state as those observed during moderate hypoxemia.
METHODS
Surgical preparation and fetal surgery. All work was conducted in accordance with the Animals (Scientific Procedures) Act (1986) on ewes bearing singleton near-term fetuses (ca. 123 d gestation). The surgical procedure has been described previously (10) . Briefly, six date-mated Romney Marsh ewes bearing singleton fetuses were operated on under aseptic conditions. Catheters were placed in the fetal brachial artery and jugular vein and a transonic flow probe was placed around the contralateral carotid artery. A pair of electrodes was sewn onto the chest wall for monitoring of fetal ECG (Cooner Wire Corp., Chatsworth, CA, U.S.A.). By use of a T incision, the skin of the scalp was peeled back. Burr holes were made in the skull overlying the parasagittal cortex, and electrodes were placed on the dura to allow monitoring of electrocortical activity. The burr holes were sealed using rubber caps and cyanoacrylate. Infrared optodes were placed on the skull overlying the parasagittal cortex and held firmly in place by molded black rubber holders sutured to the edges of the skin incision. Apposition of optodes to scalp was improved further when the scalp incision was closed over the holders and optodes. The fetus was replaced and the uterus closed in two layers. The maternal abdomen was closed and the ewe allowed to recover after placement of a catheter in the maternal recurrent metatarsal vein for administration of antibiotics.
Animal maintenance and antibiotic regime. Ewes were held in metabolic carts for the duration of the study and had access to water and hay ad libitum. Before surgery, the ewe was given prophylactic Streptapen 1 g i.m. After the surgery, the following antibiotics were given each morning: Crystapen 150 mg to the amniotic cavity, 300 mg i.v. to the ewe, and 150 mg i.v. to the fetus for 5 d and Cidomicin 40 mg to the amniotic cavity, 40 mg to the ewe i.v. for 2 d. A fetal arterial blood sample was taken each morning before giving the antibiotic regime and tested for gases and electrolytes with a BGE machine (BG Electrolytes 14008 -01 and Co-Oximeter 482, Instrumentation Laboratories, UK).
Infusion protocol. On the basis of data describing the hemodynamic response to various doses of exogenous adenosine, we chose to infuse adenosine at a rate of 3 mol· kg -1 ·min -1 into the jugular vein toward the heart. This dose has been shown to reproduce similar systemic levels to those observed in the fetus during hypoxia, i.e. in the range 4 -6 M when P a O 2 is~12-15 mm Hg (8) . In addition, it does not produce large hemodynamic changes that could interfere with the metabolic mechanisms being investigated in this study. Each infusion lasted 20 min and was succeeded by saline infusion.
Data collection. Experiments were performed on either d 2 or 3 after surgery. Hemodynamic and near-infrared spectroscopic (NIRS) data were collected for 1 h before, during, and after adenosine infusion.
Arterial and central venous pressures (SensoNor pressure transducers, Horten, Norway, and Digitimer Ltd. amplifiers, Welwyn Garden City, UK) were corrected for amniotic pressure and monitored by use of MacLab software (AD Instruments, UK). Fetal heart rate and carotid flow were monitored using MacLab software and saved to disk for off-line analysis. The electrocorticogram (ECoG) signal was monitored to confirm normal cerebral function by the presence of sleep-state cycling.
Blood samples were collected at Ϫ5, ϩ5, ϩ20, and ϩ50 min relative to the start of a 20-min adenosine infusion. At each time point, 0.5-mL samples were collected from carotid artery and jugular vein. Samples were immediately tested for gases and electrolytes (BGE machine as above) and for glucose and lactate (YSI 2300 STAT Plus), temperature corrected to fetal temperature of 39.5°C.
DO 2 values were calculated as the product of carotid flow (Q) and carotid arterial oxygen content (Ca) corrected to 39.5°C. V O 2 values were calculated using the appropriate venous oxygen content (Cv) and Fick's law:
NIRS data analysis. The use of and reliability of this technique have been discussed previously (10) and are not discussed in detail here. Briefly, spectra were saved to disk for off-line analysis. Absolute changes in chromophore concentration were calculated by subtracting from the reference spectrum (spectrum at time zero), then fitting between 780 and 900 nm to previously determined individual chromophore absorption spectra by using a least-squares multilinear regression algorithm (11, 12) . Residual changes in OD, not accounted for in the fitting process, were analyzed for the presence of large or systematic changes that might indicate the presence of another chromophore not included in the algorithm. In addition, large changes in optical path length during measurements were excluded using 2nd-order differential analysis from the 840-nm water-absorption feature (13) .
Changes in the cerebral concentration of HbO 2 and Hb are expressed in mol/L from a zero set at the start of the experiment. Because CcO concentration does not change over the time scale of the experiment, changes in the CcO signal represent changes in the amount of the oxidized enzyme present relative to the start of the experiment and not to changes in enzyme levels. A value for changes in total Hb concentration (⌬[tHb]) was generated from the sum of ⌬[HbO 2 ] and ⌬[Hb] at any time point. tHb is related to blood volume through the hematocrit.
Data presentation and statistical methods. We obtained data from six fetal sheep. All data are expressed as mean Ϯ SE; n ϭ 6 for all variables except where stated. Time points taken for analysis are Ϫ5, ϩ5, ϩ20, and ϩ50 min relative to the start of infusion. Repeated-measures ANOVA with Newman-Keuls post hoc tests were used to compare multiple data points with control (Ϫ5 min). In the case of DO 2 and V O 2 , unpaired t test was used to compare the preinfusion data with that after treatment. Owing to either missing CaBF or oxygen content data, there are too few data points in the recovery phase to analyze DO 2 or V O 2 confidently, and we have concentrated instead on analyzing the effect of adenosine treatment. Statistical significance is taken as p Ͻ 0.05.
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RESULTS
Hemodynamics, blood gases, and acid-base status. The effect of adenosine infusion on fetal hemodynamics, P a O 2 , P a CO 2 , pH a , glucose, and lactate is shown in Table 1 . Although there were no significant changes in hemodynamic variables during or after infusion, the tendency for mean arterial pressure (MAP) to fall and for CaBF to rise is consistent with the known vasodilatory properties of adenosine. Figure 2 (lower panel) shows typical data for change in tHb, which is equivalent to CBV. This variable rose rapidly after the start of the infusion period, then slowly increased for the duration of the infusion. The group mean data in Figure 3 (lower panel, right) show that the tHb reached a maximal value of 18.3 Ϯ 3.5 mol/L above control by the end of the infusion period (p Ͻ 0.05, repeated-measures ANOVA with Newman-Keuls post hoc test). tHb fell back toward control levels after the end of adenosine infusion and was not different from control levels 30 min later.
Changes in tHb.
Changes in CcO. Typical changes in oxidation of CcO are shown in Figure 2 (lower panel) . CcO rose slowly for the duration of the adenosine infusion before falling back toward baseline after cessation of the infusion. Group mean data are shown in Figure 3 (lower panel, left) . Mean CcO rose to a maximum of 0.48 Ϯ 0.01 mol/L above control by the end of infusion (p Ͻ 0.05, repeated-measures ANOVA with Newman-Keuls post hoc test). CcO oxidation was not different from control 30 min after cessation of infusion.
DISCUSSION
Fetal adenosine levels are known to increase during episodes of hypoxia, and it has been suggested that adenosine may be neuroprotective under these circumstances (14) . There are several mechanisms by which this could be achieved. Adenosine causes cerebral vasodilatation, which may lead to an 
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ADENOSINE AND FETAL METABOLISM increase in cerebral blood flow and so maintain DO 2 . In addition, adenosine has metabolic inhibitory actions that could reduce V O 2 , the overall result being to match oxygen supply and demand. Both of these aspects are addressed in this study, which describes the effect of exogenous adenosine, given in amounts that have been reported to bring plasma adenosine to similar levels to those seen in hypoxia, on fetal cerebral hemodynamics and metabolism.
The cardiovascular effects of adenosine include a myocardial A1 receptor-mediated bradycardia and, at higher concentrations, an A2 receptor-mediated vasodilatation of both cerebral and peripheral vessels (15) . We deliberately chose to infuse adenosine at a rate that would not markedly alter fetal systemic hemodynamics, and, although there was a tendency for MAP to fall and for CaBF to rise, changes in fetal hemodynamics were not statistically significant. We did, however, observe a rise in total cerebral Hb concentration measured by NIRS. tHb is derived from the sum of HbO 2 and Hb measured in all three vascular compartments and is directly related to CBV. The increase in CBV observed indicates that there was a functional cerebral vasodilatation during adenosine infusion as suggested by the hemodynamic variables. The absence of any statistically significant change in CaBF in this study group might suggest that adenosine did not have a significant effect on the arterial side of the circulation, although small changes in regional cerebral blood flow will not be detected by measurements of carotid blood flow, and we cannot say that significant differences would not emerge with a larger study group. As the major part of CBV is located in the venous circulation, it is likely that venous dilatation will dominate the changes observed here. This could result from a direct effect of adenosine on vessels, a diminution of venous outflow if venous pressure were increased secondary to increased cardiac afterload, or reduced venous return after fetal bradycardia.
Although these data do not show an increase in cerebral DO 2 with exogenous adenosine, we did observe a significant fall in V O 2 , indicating a decrease in cerebral metabolism. Karimi et al. (8) also demonstrated a fall in V O 2 during adenosine infusion, although these were data from a whole-body preparation and did not explore regional variations in metabolic response. There is, in addition, a growing body of evidence from animal models suggesting that adenosine reduces metabolic rate during and after hypoxia-ischemia (4, 16 -18) .
There are a variety of mechanisms by which adenosine could reduce whole-body V O 2 . Adenosine is involved in the reduction in fetal breathing movements observed during hypoxia (19) , and, because these body movements account for 17% of fetal whole-body V O 2 (20) , their cessation provides a substantial energy saving. Mechanisms specific to the fall in cerebral metabolism observed in this study include a reduction in glutamate-mediated excitatory neurotransmission (21, 22) and neuronal hyperpolarization (23) . Both of these actions of adenosine would promote the reduction in electron flow down the mitochondrial electron transfer chain through reducing ATP use for plasma membrane repolarization after action potential firing, thus reducing energy demand. In addition to any potential direct actions of adenosine on metabolic rate, by reducing energy demand in this way, adenosine may promote a rise in ATP levels that could act at upstream inhibitory sites (possibly at phosphofructokinase) to inhibit the electron transfer chain further. Such inhibition may result in the shunting of pyruvate into lactate production, which may account for the tendency seen in this experiment, also shown by others (8) , for lactate levels to rise during normoxemic infusion of adenosine.
Metabolic information can also be derived from the NIRS CcO signal. Both the use of NIRS to provide metabolic information via the CcO signal and the sensitivity of the method are well established (24) . The CcO signal gives information about the oxidation state of the mitochondrial population interrogated by the incident near infrared light. CcO is the final electron acceptor in the mitochondrial electron transfer chain, and its redox state is influenced by three factors: 1) the flow of reducing equivalents from the tricarboxylic acid cycle, 2) the rate of transfer of electrons from cytochrome c, and 3) the availability of oxygen at the oxygen-binding site. Despite unchanged oxygen delivery to the head during adenosine infusion, there was a significant increase in brain CcO oxidation by the end of the infusion period. This increase in CcO oxidation was similar in magnitude and direction to that previously reported during asphyxia in late-gestation fetal sheep (10) . During both hypoxia and adenosine infusion, the redox state of CcO does not appear to be influenced by DO 2 ; in the former, DO 2 fell, and, in the latter, it stayed stable, and yet in both instances, CcO became more oxidized. 
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NO is a possible link between adenosine and alterations in oxidative phosphorylation. Adenosine increases NO release from astrocytes (25) , and NO is known to interact with components of the mitochondrial electron transfer chain (26) . NO can inhibit metabolism both reversibly and irreversibly (27, 28) ; the reversible inhibition is due to competition between NO and O 2 for the cytochrome oxidase binuclear center, the site at which molecular oxygen is reduced to water. Because this is a competitive inhibition, NO effects are greater a) when PO 2 is low and b) when NO is high, both of which may be the case during profound hypoxia. Irreversible inhibition, however, occurs when mitochondria are exposed to high NO levels for several hours. In this instance, the inhibition is due to permanent nitrosylation of protein thiols in mitochondrial complex I and removal of iron from iron-sulfur centers. However, from our present knowledge, it seems unlikely that transient alterations in NO concentration could result in mitochondrial oxidation as observed in this study. The effect of reversible inhibition on cellular redox would be to allow electrons to build up in the transfer chain and cause reduction of the Cu A moiety rather than the oxidation reported here. Whereas irreversible inhibition would block electron transfer at complex 1 and lead to Cu A oxidation, it is unlikely that this could occur within the short time course (20 min) of this experiment. In addition, the redox state of Cu A returned to baseline levels within 30 min after stopping adenosine infusion.
A mechanism that could account for CcO oxidation during asphyxia is suggested by data from Yager et al. (29) , who calculated CcO redox state using the acetoacetate/␤-hydroxybutyrate substrate couple. In their experiments, hypoxia-ischemia caused a reduction followed by an oxidation of mitochondrial redox. They suggest that a reduction in the flow of reducing equivalents, not low oxygen delivery, is the limiting factor in respiration during severe hypoxia in immature animals. If this is the case, it would explain our previous findings during asphyxia (10) and, combined with the data presented here, suggest that an increase in endogenous adenosine occurring during hypoxia may decrease the flow of reducing equivalents down the oxidative phosphorylation pathway and so lead to a decrease in cerebral metabolism.
Our data demonstrate that infusion of adenosine in the late-gestation ovine fetus results in a fall in cerebral metabolism similar to that observed previously during asphyxia. There is now circumstantial evidence to suggest that adenosine acts as an endogenous neuroprotective agent in the immature brain. However, further work using pharmacologic interventions to augment or block the endogenous adenosine response to hypoxia, coupled with measurement of sequelae in terms of neural structure and function, will be needed to clarify whether adenosine is indeed neuroprotective.
